 TORONTO and HOUSTON, Feb. 12, 2021 GLOBE NEWSWIRE -- Medicenna Therapeutics Corp. Medicenna or Company NASDAQ: MDNA, TSX: MDNA, a clinical stage immuno-oncology company, today announced its financial results and operational highlights for the quarter ended December 31, 2020. All dollar amounts are expressed in Canadian currency unless otherwise noted. 